Send PM
Followers 116
Posts 18658
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Monday, 06/20/2022 2:37:28 PM

Monday, June 20, 2022 2:37:28 PM

Post# of 3158
Do you remember the FDA advisory panel vote regarding Biogen's aducanumab?

...the U.S. Food and Drug Administration (FDA) Peripheral and Central Nervous System Drugs Advisory Committee voted 1 yes, 8 no and 2 uncertain on the question, “Does Study 302 (EMERGE), viewed independently and without regard for Study 301 (ENGAGE), provide strong evidence that supports the effectiveness of aducanumab for the treatment of Alzheimer’s disease?”. The Advisory Committee also voted 0 yes, 7 no and 4 uncertain on the question, “Does Study 103 (PRIME) provide supportive evidence of the effectiveness of aducanumab for the treatment of Alzheimer’s disease?”, and 5 yes, 0 no and 6 uncertain on the question, “Has the Applicant presented strong evidence of a pharmacodynamic effect of aducanumab on Alzheimer’s disease pathophysiology?”. Finally, the Advisory Committee voted 0 yes, 10 no and 1 uncertain on the question, “In light of the understanding provided by the exploratory analyses of Study 301 and Study 302, along with the results of Study 103 and evidence of a pharmacodynamic effect on Alzheimer’s disease pathophysiology, it is reasonable to consider Study 302 as primary evidence of effectiveness of aducanumab for the treatment of Alzheimer’s disease?”...



The Food and Drug Administration on Monday approved the first new medication for Alzheimer’s disease in nearly two decades, a contentious decision made despite opposition from the agency’s independent advisory committee and some Alzheimer’s experts who said there was not enough evidence that the drug can help patients.



Good luck and GOD bless,

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Recent ACAD News

Branded Legacy, Inc. Reduces Authorized Shares By 300 Million BLEG Sep 27, 2022 11:53 AM

Acquisition Completed: Endexx (EDXC)'s HYLA Secures 200k+ Unit Order; 4,500 Puffs per Unit AVXL Sep 27, 2022 9:33 AM

Integrated Ventures is set to report 254% annual revenue growth, fueled by expansion of crypto mining operations INTV Sep 27, 2022 9:22 AM

SNAKES & LATTES INC. (OTC: FUNN) is Pleased to Report an Almost 200% Increase in Year Over Year FY22 Revenue at $6,064,896, up From $2,027,988 for FY21, With Gross Profits up From $1,369,514 to $4,223,022 FUNN Sep 27, 2022 8:14 AM

ILUS Confirms Its First Investment Project in Serbia ILUS Sep 26, 2022 12:23 PM

Thunder Energies Engages Geological Experts For Gold and Minerals Assessment TNRG Sep 26, 2022 9:56 AM

CERRADO GOLD CONFIRMS OVER 250 METRES OF MINERALIZED STRIKE AT GOGO´ DA ONC¸A EXPLORATION TARGET AT ITS MONTE DO CARMO PROJECT, BRAZIL CRDOF Sep 26, 2022 9:45 AM

HealthLynked Announces Upgrades to its MedOfficeDirect Ecommerce Site for Discount Medical Supplies HLYK Sep 23, 2022 8:00 AM

ResGreeen Uses Open-Source Robot Operating System (ROS) to Enhance Integration and Simulation for LilBuddy AMR RGGI Sep 22, 2022 1:58 PM

Branded Legacy, Inc. Partners With Apple Rush Company, Inc. BLEG Sep 22, 2022 12:31 PM

Good Gaming Inc. Sells Out Its Water Bear PFP Mint In Only 45 Minutes With The Premiere of The Genesis Collections GMER Sep 22, 2022 9:15 AM

TRU Opens Up New Copper-Gold-Silver Discovery at Golden Rose TRUIF Sep 22, 2022 9:04 AM

PSYC's Spotlight Media Corp to Host MJBizCon Kickoff Party at Brooklyn Bowl Las Vegas PSYC Sep 22, 2022 8:30 AM

SFLMaven: New NFT Metaverse Jewelry Pieces to Be Released in Q3 2022 SFLM Sep 22, 2022 6:30 AM

Ludwig Files A Patent That Could Be a Major Technology Breakthrough in Healthcare LUDG Sep 22, 2022 12:00 AM